CFCatarina Machado Ferreira

Catarina Machado Ferreira

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Catarina Machado Ferreira has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Early IL-10 promotes vasculature-associated CD4+ T cells unable to control Mycobacterium tuberculosis infection

    by Catarina M. Ferreira, Ana Margarida Barbosa, Palmira Barreira-Silva, Ricardo Silvestre, Cristina Cunha, Agostinho Carvalho, Fernando Rodrigues, Margarida Correia-Neves, António G. Castro, Egídio Torrado

    Cytokine-producing CD4 + T cells play a crucial role in the control of Mycobacterium tuberculosis infection; however, there is a delayed appearance of effector T cells in the lungs following aerosol infection. The immunomodulatory cytokine IL-10 antagonizes control of M . tuberculosis infection through mechanisms associated with reduced CD4 + T cell responses. Here, we show that IL-10 overexpression only before the onset of the T cell response impaired control of M . tuberculosis growth; during chronic infection, IL-10 overexpression reduced the CD4 + T cell response without affecting the outcome of infection. IL-10 overexpression early during infection did not, we found, significantly impair the kinetics of CD4 + T cell priming and effector differentiation. However, CD4 + T cells primed and differentiated in an IL-10–enriched environment displayed reduced expression of CXCR3 and, because they did not migrate into the lung parenchyma, their ability to control infection was limited. Importantly, these CD4 + T cells maintained their vasculature phenotype and were unable to control infection, even after adoptive transfer into low IL-10 settings. Together our data support a model wherein, during M . tuberculosis infection, IL-10 acts intrinsically on T cells, impairing their parenchymal migratory capacity and ability to engage with infected phagocytic cells, thereby impeding control of infection.


  • Open Access

    Myeloid HIF‐1α regulates pulmonary inflammation during experimental Mycobacterium tuberculosis infection

    by Mariana Resende, Catarina M. Ferreira, Ana Margarida Barbosa, Marcos S. Cardoso, Jeremy Sousa, Margarida Saraiva, António G. Castro, Rui Appelberg, Egídio Torrado

    Summary: The transcription factor hypoxia‐inducible factor‐1 alpha (HIF‐1α) is a key regulator of the response and function of myeloid cells in hypoxic and inflammatory microenvironments. To define the role of HIF‐1α in tuberculosis, the progression of aerosol Mycobacterium tuberculosis infection was analysed in mice deficient in HIF‐1α in the myeloid lineage (mHIF‐1α−/−). We show that myeloid HIF‐1α is not required for the containment of the infection, as both wild‐type (WT) and mHIF‐1α−/− mice mounted normal Th1 responses and maintained control of bacterial growth throughout infection. However, during chronic infection mHIF‐1α−/− mice developed extensive lymphocytic inflammatory involvement of the interstitial lung tissue and died earlier than WT mice. These data support the hypothesis that HIF‐1α activity coordinates the response of myeloid cells during M. tuberculosis infection to prevent excessive leucocyte recruitment and immunopathological consequences to the host.


  • The impact of IL-10 dynamic modulation on host immune response against visceral leishmaniasis

    by Inês Mesquita, Carolina Ferreira, Ana Margarida Barbosa, Catarina Machado Ferreira, Diana Moreira, Agostinho Carvalho, Cristina Cunha, Fernando Rodrigues, Ricardo Jorge Dinis-Oliveira, Jérôme Estaquier, et al.


  • Open Access

    A Nonribosomal Peptide Synthase Gene Driving Virulence in Mycobacterium tuberculosis

    by Kiranmai Bhatt, Henrique Machado, Nuno S. Osório, Jeremy Sousa, Filipa Cardoso, Carlos Magalhães, Bing Chen, Mei Chen, John Kim, Albel Singh, et al.

    Over 10 million people developed tuberculosis (TB) in 2016, and over 1.8 million individuals succumbed to the disease. These numbers make TB the ninth leading cause of death worldwide and the leading cause from a single infectious agent. Therefore, finding novel therapeutic targets in Mycobacterium tuberculosis , the pathogen that causes most cases of human TB, is critical. In this study, we reveal a novel virulence factor in M. tuberculosis , the nrp gene. The lack of nrp highly attenuates the course of M. tuberculosis infection in the mouse model, which is particularly relevant in immune-deficient hosts. This is very relevant as TB is particularly incident in immune-suppressed individuals, such as HIV patients.


  • Development of Inhalable Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in Microparticulate System for Antituberculosis Drug Delivery

    by Margarida S. Miranda, Márcia T. Rodrigues, Rui M. A. Domingues, Rui R. Costa, Elvira Paz, Carlos Rodríguez‐Abreu, Paulo Freitas, Bernardo G. Almeida, Maria Alice Carvalho, Carine Gonçalves, et al.

    Tuberculosis (TB) is an infectious disease which affects millions of people worldwide. Inhalable polymeric dry powders are promising alternatives as anti‐TB drug carriers to the alveoli milieu and infected macrophages, with potential to significantly improve the therapeutics efficiency. Here, the development of a magnetically responsive microparticulate system for pulmonary delivery of an anti‐TB drug candidate (P3) is reported. Microparticles (MPs) are developed based on a cast method using calcium carbonate sacrificial templates and incorporate superparamagnetic iron oxide nanoparticles to concentrate MPs in alveoli and enable drug on demand release upon actuation of an external alternate magnetic field (AMF). The MPs are shown to be suitable for P3 delivery to the lower airways and for alveolar macrophage phagocytosis. The developed MPs reveal unique and promising features to be used as an inhalable dry powder allowing the AMF control over dosage and frequency of drug delivery anticipating improved TB treatments.


  • Metabolic Host Response to Intracellular Infections

    by Catarina M. Ferreira, Ana Margarida Barbosa, Inês M. Pereira, Egídio Torrado

    The interaction between intracellular bacterial pathogens with the host immune response can result in multiple outcomes that range from asymptomatic clearance to the establishment of infection. At its core, these interactions result in multiple metabolic adaptations of both the pathogen and its host cell. There is growing evidence that the host metabolic response plays a key role in the development of immune responses against the invading pathogen. However, successful intracellular pathogens have developed multiple mechanisms to circumvent the host response to thrive in the intracellular compartment. Here, we provide a brief overview on the crucial role of fundamental metabolic host responses in the generation of protective immunity to intracellular bacterial pathogens and discuss some of the mechanisms used by these pathogens to exploit the host metabolic response to their own advantage. This understanding will further our knowledge in host-pathogen interactions and may provide new insights for the development of novel therapies.


  • Open Access

    Immune-evasion Strategies of Mycobacteria and Their Implications for the Protective Immune Response

    by Alexandra G. Fraga, Ana Margarida Barbosa, Catarina M. Ferreira, João Fevereiro, Jorge Pedrosa, Egídio Torrado

    Mycobacteria are intracellular pathogens that have macrophages as their main host cells. However, macrophages are also the primary line of defense against invading microorganisms. To survive in the intracellular compartment, virulent mycobacteria have developed several strategies to modulate the activation and the effector functions of macrophages. Despite this, antigen-specific T cells develop during infection. While T cell responses are critical for protection they can also contribute to the success of mycobacteria as human pathogens, as immunopathology associated with these responses facilitates transmission. Here, we provide a brief overview of different immune-evasion strategies of mycobacteria and their impact on the protective immune response. This understanding will further our knowledge in host-pathogen interactions and may provide critical insights for the development of novel host-specific therapies.